2025-01-17 - Analysis Report
## UnitedHealth Group Inc. (UNH) Stock Review

**1. Performance vs. S&P 500 (VOO):**

UnitedHealth Group Inc. (UNH) is a diversified healthcare company offering a range of products and services.  Over the period analyzed, UNH significantly outperformed the S&P 500 (VOO).  The cumulative return for UNH is 136.65%, while the VOO's is 116.43%.  This represents a difference of 20.2 percentage points.  The relative outperformance, considering historical volatility, is at the 17.4th percentile.


**2. Recent Price Movement:**

* **Closing Price:** $513.05
* **5-Day Moving Average:** $532.41
* **20-Day Moving Average:** $512.69
* **60-Day Moving Average:** $555.65

The current price is below all three moving averages, suggesting a potential downward trend in the short term.  The 5-day MA being significantly higher indicates a recent price drop.

**3. Technical Indicators and Expected Return:**

* **RSI:** 53.89 (Slightly above neutral; not overbought or oversold)
* **PPO:** 0.95 (Positive, suggesting upward momentum)
* **Delta_Previous_Relative_Divergence:** -4.5% (Short-term bearish divergence)
* **Expected Return (vs. S&P 500):** 380.5% over the long term (2+ years). This signifies a considerably higher return expectation compared to the benchmark.  The large expected return should be considered within the context of the model's inherent uncertainty.

The current price of $513.06, being below the moving averages, suggests a recent price drop rather than a sharp rebound or decline.  The negative divergence warrants caution.


**4. Recent Earnings Analysis:**

| Date       | EPS    | Revenue        | Notes                                  |
|------------|--------|-----------------|------------------------------------------|
| 2024-11-04 | 6.56   | $100.82B       |                                          |
| 2024-08-09 | 4.58   | $98.86B        |                                          |
| 2024-05-09 | -1.53  | $99.80B        | Significant EPS decline; investigate cause |
| 2023-11-06 | 6.31   | $92.36B        |                                          |
| 2024-11-04 | 6.31   | $92.36B        | Duplicate entry; likely a data error     |


There's a noticeable fluctuation in EPS, with a significant drop in Q2 2024.  Revenue remains relatively stable and high.  The duplicate entry for 2024-11-04 needs clarification.  Further investigation into the Q2 2024 EPS decline is necessary.


**5. Financial Information:**

**Revenue and Profitability:** Revenue is consistently high, with slight fluctuations. Profit margins are generally strong, albeit a small decline in recent quarters.

**Capital and Profitability:** Equity shows growth, but ROE is volatile, indicating fluctuating profitability.  The negative ROE in Q1 2024 is a concern requiring investigation.


**7. Overall Analysis:**

UNH has shown strong historical outperformance compared to the S&P 500.  However, recent price action suggests a potential short-term downturn.  While long-term projections are optimistic, recent quarterly results reveal inconsistencies, particularly the significant drop in Q2 2024 EPS. The negative ROE in Q1 2024 is also a cause for concern.  Further investigation into the reasons behind the EPS decline and fluctuating ROE is crucial before making investment decisions.  The strong long-term projections should be viewed cautiously given recent volatility.  A more thorough fundamental analysis is warranted.

**8. Disclaimer:** This analysis is for informational purposes only and does not constitute financial advice.  Investment decisions should be based on your own thorough research and consideration of your risk tolerance.
